Delivery Order SPE2DB24D2205-SPE2DB25FDUNP

Award Date 11/21/24
Potential Completion Date 12/13/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,228.94 firm fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,714.90 firm fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,857.45 firm fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,626.90 firm-fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,857.45 firm fixed-price delivery order is for the supply of 4567089353 ZILRETTA 32 MG VIALS, with a completion date of February 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $4,457.88, is for the supply of ZILRETTA 32 MG VIALS. The contract has a firm fixed price and an ultimate completion date of May 2, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ZILRETTA 32 MG VIALS. The $3,343.41 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 11, 2025 with a completion date of July 3, 2025. The contract is not set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award, valued at $1,402.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZILRETTA 32 MG VIALS, a specialty medication. It is a firm fixed-price delivery order contract with a period of performance through November 8, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,114.47, is for the delivery of ZILRETTA 32 MG VIALS, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,457.88 firm fixed-price delivery order is for the supply of 4,568,236,556 vials of the medication ZILRETTA 32 MG. The contract has a performance period extending through June 4, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDUNP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,450.76 firm fixed-price delivery order is for the supply of 32 mg vials of the drug ZILRETTA. The contract has an ultimate completion date of December 13, 2024 and was awarded on November 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have any set-aside designation, indicating open competition.

Generated 2/20/25, 9:36 AM